0001193125-15-325985.txt : 20150923 0001193125-15-325985.hdr.sgml : 20150923 20150923085252 ACCESSION NUMBER: 0001193125-15-325985 CONFORMED SUBMISSION TYPE: 8-A12B PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20150923 DATE AS OF CHANGE: 20150923 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Novocure Ltd CENTRAL INDEX KEY: 0001645113 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 000000000 FILING VALUES: FORM TYPE: 8-A12B SEC ACT: 1934 Act SEC FILE NUMBER: 001-37565 FILM NUMBER: 151120364 BUSINESS ADDRESS: STREET 1: LE MASURIER HOUSE, LA RUE LE MASURIER CITY: ST. HELIER STATE: Y9 ZIP: JE2 4YE BUSINESS PHONE: 44 (0)15 3475 6700 MAIL ADDRESS: STREET 1: LE MASURIER HOUSE, LA RUE LE MASURIER CITY: ST. HELIER STATE: Y9 ZIP: JE2 4YE 8-A12B 1 d72043d8a12b.htm FORM 8-A12B Form 8-A12B

As filed with the Securities and Exchange Commission on September 23, 2015

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 8-A

 

 

FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES

PURSUANT TO SECTION 12(b) OR (g) OF THE

SECURITIES EXCHANGE ACT OF 1934

 

 

NovoCure Limited

(Exact name of registrant as specified in its charter)

 

 

 

Jersey (Channel Islands)   Not Applicable
(State of incorporation or organization)   (I.R.S. Employer Identification No.)

 

Le Masurier House

La Rue Le Masurier

St. Helier, Jersey

   JE2 4YE
(Address of principal executive offices)   (Zip Code)

Securities to be registered pursuant to Section 12(b) of the Act:

 

Title of each class

to be so registered

  

Name of each exchange on which

each class is to be registered

Ordinary Shares, no par value   The NASDAQ Stock Market LLC

 

 

If this form relates to the registration of a class of securities pursuant to Section 12(b) of the Exchange Act and is effective pursuant to General Instruction A.(c), check the following box.  x

If this form relates to the registration of a class of securities pursuant to Section 12(g) of the Exchange Act and is effective pursuant to General Instruction A.(d), check the following box.  ¨

Securities Act registration statement file number to which this form relates:

333-206681

Securities to be registered pursuant to Section 12(g) of the Act:

None

Title of Class

 

 

 

Item 1. Description of Registrant’s Securities to be Registered.

The description of the ordinary shares, no par value, of NovoCure Limited, a Jersey (Channel Islands) public limited company (the “Registrant”), as included under the caption “Description of Share Capital” in the prospectus forming a part of the Registration Statement on Form S-1, as originally filed with the Securities and Exchange Commission (the “Commission”) on August 31, 2015 (Registration No. 333-206681), including exhibits, as amended September 21, 2015, and as may be subsequently amended from time to time (the “Registration Statement”), is hereby incorporated by reference. In addition, the above-referenced description included in any prospectus relating to the Registration Statement filed with the Commission pursuant to Rule 424(b) under the Securities Act of 1933, as amended, shall be deemed to be incorporated by reference herein.

 

Item 2. Exhibits.

None.

SIGNATURE

Pursuant to the requirements of Section 12 of the Securities Exchange Act of 1934, the registrant has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized.

 

Date: September 23, 2015     NOVOCURE LIMITED
    By:   /s/ Wilhelmus Groenhuysen
      Name:   Wilhelmus Groenhuysen
      Title:   Chief Financial Officer